Results 291 to 300 of about 126,514 (307)

Cancer stem cells in osteosarcoma

Cancer Letters, 2017
Marta Tellez-Gabriel, Dominique Heymann   +1 more
exaly  

Current Therapeutic Strategies and Novel Approaches in Osteosarcoma

Cancers, 2013
KŌSEI Ando, Marie-Françoise Heymann, Kanji Mori   +2 more
exaly  

Bone Microenvironment and Osteosarcoma Metastasis

International Journal of Molecular Sciences, 2020
Ye Tian, Zhihao Chen, Peihong Su
exaly  

Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials

Annals of Oncology, 2012
A Mctiernan, Matthew R Sydes, L Trani
exaly  

Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma

Proceedings of the National Academy of Sciences of the United States of America, 2014
Jennifer A Perry, Adam Kiezun, Peter Tonzi   +2 more
exaly  

Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics

Modern Pathology, 2010
Akihiko Yoshida, Tetsuo Ushiku, Hitoshi Tsuda   +2 more
exaly  

A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study

Annals of Oncology, 2012
Giovanni Grignani, Emanuela Palmerini, Ymera Pignochino   +2 more
exaly  

Survival after recurrent osteosarcoma: Data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials

European Journal of Cancer, 2011
Hans Gelderblom, Matthew R Sydes, Vivien H C Bramwell   +2 more
exaly  

Review of Osteosarcoma and Current Management

Rheumatology and Therapy, 2016
Hue H Luu
exaly  

Surface osteosarcoma: Clinical features and therapeutic implications

Journal of Bone Oncology, 2015
N Nouri, M Bouaziz
exaly